BioCentury
ARTICLE | Distillery Therapeutics

Infectious disease

June 6, 2018 7:05 PM UTC

Mouse studies identified a macrocyclic Trypanosoma rhodesain inhibitor that could help treat African trypanosomiasis. Screening of a library of cysteine protease inhibitors, in vitro activity and para...

BCIQ Company Profiles

ETH Zurich

Roche

BCIQ Target Profiles

Trypanosoma rhodesain